Constitutively active PI3K/Akt/mTOR signaling is observed in many types of solid and blood tumors, including T-cell acute lymphoblastic leukemia (T-ALL), where it portends a poorer prognosis and negatively influences response to therapeutic treatments [7]. Here, MTOR is linked to T-cell acute lymphoblastic leukemia.